Here's Eli Lilly's Competitive Advantage in GLP-1 Obesity Drugs and Abbott's Supporting Role
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Novo Nordisk A/S
New Pet Medications Look Much More Like Human Medications
If you want to understand how different the human and animal drug and vaccine industries have historically been, you don't…
Liver disease is the new use of weight loss drugs
Image of a healthy liver not ravaged by fatty liver disease. BSIP | fake images Do you think a friend…
GRANOLAS Stock Drives Europe to Record Highs, Drawing Magnificent 7 Comparisons
The chart of the German stock price index DAX is displayed on the stock exchange in Frankfurt, Germany, on January…
GRANOLAS Stock Drives Europe to Record Highs, Drawing Magnificent 7 Comparisons
The chart of the German stock price index DAX is displayed on the stock exchange in Frankfurt, Germany, on January…
What you need to know about health coverage for new weight loss drugs
Many American companies are dealing with health insurance coverage issues for workers when it comes to GLP-1 weight loss drugs.…
In this fast-paced bull market, we are increasing our Club price targets by 4 stocks
It's been difficult to keep up. That's the story of this year's big stock winners. They keep winning and winning…
Why We Would Consider Buying More Eli Lilly Stock If It Were Down
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Novo Nordisk and Eli Lilly address supply issues
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…
Eli Lilly's Weight Loss Drug May Treat Fatty Liver Disease
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…